Dr Nicole Dmochowska is a Researcher Exchange and Development within Industry (REDI) Fellow (MTPConnect), working closely with Adelaide-based Ferronova to develop cancer imaging technologies. She was awarded a PhD in Medicine at the University of Adelaide and the South Australian Health and Medical Research Institute in 2020 and then joined the Future Industries Institute as a research associate. During her PhD, she was awarded a prestigious William T Southcott Nuclear Medicine Scholarship. She is a board member of the Australian Society of Molecular Imaging which works towards promoting the multidisciplinary field of molecular imaging, as well as fostering national and international collaborations. Dr Dmochowska has a strong passion for... Read more
About me
Dr Nicole Dmochowska is a Researcher Exchange and Development within Industry (REDI) Fellow (MTPConnect), working closely with Adelaide-based Ferronova to develop cancer imaging technologies. She was awarded a PhD in Medicine at the University of Adelaide and the South Australian Health and Medical Research Institute in 2020 and then joined the Future Industries Institute as a research associate. During her PhD, she was awarded a prestigious William T Southcott Nuclear Medicine Scholarship. She is a board member of the Australian Society of Molecular Imaging which works towards promoting the multidisciplinary field of molecular imaging, as well as fostering national and international collaborations. Dr Dmochowska has a strong passion for mentoring the next generation of women in STEM and is actively involved with the South Australian Academy for Gender Equity in STEM.
Dr Dmochowska has extensive experience in all aspects of the preclinical development of imaging agents, from in vitro validation to in vivo experimental/model development and in vivo testing. During her PhD, she developed several PET imaging tracers against intestinal inflammation and fibrosis in a murine model of inflammatory bowel disease.
Since joining the University of South Australia’s Future Industries Institute, her research has focused on developing small molecule tumour targeting imaging contrast agents aimed at improving the imaging of primary tumour lesions. Dr Dmochowska is a key member of Ferronova’s research team that is building on first generation FerroTrace to develop FerroTrace-FAPi, designed to target the stroma of solid tumours, leading to improved delineation on MRI. She also led the development of a FerroTrace-PSMA formulation and the preclinical investigation of several immuno-MRI and PET agents aimed at improving the staging of head and neck cancers.
About me
Editorial board member of Discover Imaging (Springer Nature)
Board member of the Australian Society of Molecular Imaging
About me
Doctor of Philosophy (Medicine) University of Adelaide
Bachelor of Health Scineces, First Class Honours, majoring in Pharmacology University of Adelaide
Bachelor of Science, majoring in Chemistry and Pharmacology University of Adelaide
Research
Excludes commercial-in-confidence projects.
Preclinical investigation of an ultrabright indocyanine green nanoformulation towards improved intraoperative fluorescence-guided surgery of pancreatic tumours, Tour de Cure Ltd, 01/01/2024 - 04/03/2025
Preclinical validation of a new molecular magnetic resonance imaging of glioblastoma towards improved image-guided treatment, Tour de Cure Ltd, 01/07/2023 - 01/07/2024
FAPi-MRI towards Better target delineation of high-grade Gliomas, Neurosurgical Research Foundation, 30/08/2021 - 31/08/2022
Research
Research outputs for the last seven years are shown below. Some long-standing staff members may have older outputs included. To see earlier years visit ORCID or Scopus
Open access indicates that an output is open access.
| Year | Output |
|---|---|
| 2024 |
Open access
1
|
| 2023 |
Open access
3
3
1
|
| 2023 |
Open access
3
2
1
|
| 2022 |
4
5
6
|
| 2022 |
10
9
5
|
| 2020 |
Open access
6
7
|
| 2019 |
Open access
28
27
49
|
| 2019 |
Open access
11
10
3
|
| 2018 |
Open access
34
24
8
|
Research
| Details | Registry | Status |
|---|---|---|
|
Thierry, Benjamin; Nelson, Melanie Ruth Maria; Milanova, Valentina; Dmochowska, Nicole; Pham, Thi Hanh Nguyen; Hawkett, Brian Stanley |
World | Filed |
External engagement & recognition
| Organisation | Country |
|---|---|
| Dana-Farber Cancer Institute | UNITED STATES |
| Ferronova | AUSTRALIA |
| Harvard University | UNITED STATES |
| Purdue University | UNITED STATES |
| Royal Adelaide Hospital | AUSTRALIA |
| South Australian Health and Medical and Research Institute (SAHMRI) | AUSTRALIA |
| University of Adelaide | AUSTRALIA |
| University of South Australia | AUSTRALIA |
| University of Sydney | AUSTRALIA |
| Western Sydney University | AUSTRALIA |
External engagement & recognition
| Engagement/recognition | Year |
|---|---|
FellowshipResearcher Exchange and Development within Industry Fellowship |
2023 |
Secretary of the BoardAustralian Society of Molecular Imaging |
2023 |
FellowshipResearcher Exchange and Development within Industry Fellowship |
2022 |
Secretary of the BoardAustralian Society of Molecular Imaging |
2022 |
Board MemberAustralian Society of Molecular Imaging |
2021 |
Secretary of the BoardAustralian Society of Molecular Imaging |
2021 |
Alavi-Mandell Award - Highly commended paperSociety of Nuclear Medicine and Molecular Imaging |
2020 |
Board MemberAustralian Society of Molecular Imaging |
2020 |
Board MemberAustralian Society of Molecular Imaging |
2019 |
Teaching & student supervision
Supervisions from 2010 shown
| Thesis title | Student status |
|---|---|
| 110450 - Development of a theranostic agent for image-guided and radiosensitisation of pancreatic cancer | Current |
| 111188 - Development of brain tumour-targeting ICG nanoformulations for fluorescence-guided neurosurgery | Current |
| New radiobiological insights using a microphysiological device enabling long-term culture of patient-derived brain tumour tissue slices and cerebral organoid slices | Current |
| Next generation bioengineered in vitro tumour models | Current |
| Systematic characterisation of existing and new models of the vaginal mucosa and their application to assess the vaginal delivery of nanomedicine | Current |
| A nanomedicine approach for immune checkpoint inhibition: towards better and safer cancer immunotherapy | Completed |
